skip to content
The $800 million pill : the truth behind the cost of new drugs
ClosePreview this item

The $800 million pill : the truth behind the cost of new drugs

Author: Merrill Goozner
Publisher: Berkeley : University of California Press, ©2004.
Edition/Format:   Book : EnglishView all editions and formats
Summary:
"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: Merrill Goozner
ISBN: 0520239458 9780520239456 0520246705 9780520246706
OCLC Number: 53223691
Description: 297 p. ; 24 cm.
Contents: pt. 1: Biohype. The longest search ; Rare profits ; The source of the new machine --
pt. 2: Directed research. A public-private partnership ; The divorce ; Breakthrough! ; The failed crusade? --
pt. 3: Big Pharma. Me too! ; The $800 million pill ; The future of innovation.
Other Titles: Eight hundred million dollar pill
Responsibility: Merrill Goozner.
More information:

Abstract:

This is an useful text for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing  Read more...

Reviews

Editorial reviews

Publisher Synopsis

"American expenditures on prescription drugs doubled between 1990 and 2000 and currently account for close to ten percent of total healthcare costs. Concerns about availability to seniors and the Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


<http://www.worldcat.org/oclc/53223691>
library:oclcnum"53223691"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/53223691>
rdf:typeschema:Book
rdfs:seeAlso
rdfs:seeAlso
rdfs:seeAlso
rdfs:seeAlso
schema:about
schema:about
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"Staatliche Einrichtung."
schema:about
rdf:typeschema:Intangible
schema:name"Consommateurs--Éducation."
schema:about
rdf:typeschema:Intangible
schema:name"Industrie pharmaceutique."
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"Biomedical Research--economics."
schema:about
rdf:typeschema:Intangible
schema:name"Forschungsfinanzierung."
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"Drug Industry--economics."
schema:about
rdf:typeschema:Intangible
schema:name"Öffentliche Förderung."
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"Drug Therapy--economics."
schema:about
rdf:typeschema:Intangible
schema:name"Pharmazeutische Industrie."
schema:about
rdf:typeschema:Intangible
schema:name"Arzneimittelforschung."
schema:about
schema:author
schema:copyrightYear"2004"
schema:datePublished"2004"
schema:description"pt. 1: Biohype. The longest search ; Rare profits ; The source of the new machine -- pt. 2: Directed research. A public-private partnership ; The divorce ; Breakthrough! ; The failed crusade? -- pt. 3: Big Pharma. Me too! ; The $800 million pill ; The future of innovation."
schema:description""Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket."
schema:inLanguage"en"
schema:name"The $800 million pill : the truth behind the cost of new drugs"
schema:numberOfPages"297"
schema:publisher
rdf:typeschema:Organization
schema:name"University of California Press"
umbel:isLike<http://bnb.data.bl.uk/id/resource/GBA4Z1147>
Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.